[Top ten research advances of ophthalmology in China (2009-2013)].
In order to showcase the major research advances in ophthalmology of the recent five years (2009-2013) in China, the 11th Committee of the Ophthalmic Division of Chinese Medical Association launched the selection of Top Ten Research Advances of Ophthalmology in China. Each ophthalmic subspecialty group voted its top ten research advances and chose two out of ten to join the selection. The Committee voted top ten out from all candidates and announced the final result with honor. The following research advances were selected as the Top Ten Research Advances of Ophthalmology in China: Innovative theory and its application of fungal keratitis; Increased gradient pressure between IOP and ICP is the main cause of glaucomatous optic neuropathy; Domestic developed anti-VEGF medicine Conbercept has been applied successfully in the treatment of choriodal neovascularization; IL-23/IL-17 pathway and their regulation in the pathogenesis of uveitis; The creation of myopic animal model and the biochemical mechanism of myopia; Specialists' consensus on diagnosing amblyopia in children; Generation of induced pluripotent stem cells from human fibroblasts of the Tenon's capsule; The development and application of endoscopic navigation system in orbital surgery; Studies of pathogenesis on congenital cataract candidate gene mutations; The regulation for the diagnosis and treatment of pediatric retinal diseases in China and its extension.
Ningli
N
Wang
D000550:Amblyopia / Q000175:diagnosis; D000818:Animals; D035843:Biomedical Research; D002386:Cataract / Q000235:genetics; D002681:China; D020256:Choroidal Neovascularization / Q000188:drug therapy; D004195:Disease Models, Animal; D015821:Eye Infections, Fungal; D005901:Glaucoma / Q000150:complications; D006801:Humans; D007429:Intraocular Pressure; D007634:Keratitis / Q000382:microbiology; D009885:Ophthalmology; D009915:Orbit / Q000601:surgery; D039904:Pluripotent Stem Cells; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D012164:Retinal Diseases / Q000175:diagnosis / Q000628:therapy; D058475:Tenon Capsule / Q000166:cytology; D014605:Uveitis / Q000209:etiology
D011993:Recombinant Fusion Proteins; C527363:KH902 fusion protein